Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Viatris (VTRS)

Viatris Reports Q3 2026 Results, Raises Guidance Midpoints and Plans Pacira Acquisition

Mixed Impact 4 of 5 earnings

Viatris reported third-quarter 2026 total revenues of $3.75 billion and a U.S. GAAP net loss of $325 million alongside adjusted EBITDA of $1.20 billion. The company raised its full-year 2026 financial guidance midpoints across all metrics and announced plans to acquire Pacira BioSciences for $1.65 billion. Shareholders also benefited from $717 million in year-to-date capital returns, including share repurchases.

Key points

  • Total revenues were $3.75 billion in the third quarter of 2026, matching the prior-year period.
  • U.S. GAAP net loss widened to $325 million from $128 million in the third quarter of 2025.
  • Adjusted EBITDA reached $1.20 billion, up 4% on a reported basis from the prior-year period.
  • The company agreed to acquire Pacira BioSciences for $36.50 per share in cash, representing an equity value of $1.65 billion.

The filing

CompanyViatris (VTRS)
Form8-K, current report
Filed with the SECNov 5, 2026, 7:45 AM ET
Accession number0001792044-26-000053

Items reported: 2.02 Results of Operations8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 6, 2026, 8:16 AM ET, from this filing only.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.